<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="104128">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01816061</url>
  </required_header>
  <id_info>
    <org_study_id>D0637-R</org_study_id>
    <nct_id>NCT01816061</nct_id>
  </id_info>
  <brief_title>Executive Functioning in TBI From Rehabilitation to Social Reintegration: COMPASS</brief_title>
  <official_title>Executive Functioning in TBI From Rehabilitation to Social Reintegration: COMPASS</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Department of Veterans Affairs</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Moss Rehabilitation Research Institute</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Department of Veterans Affairs</source>
  <oversight_info>
    <authority>United States: Federal Government</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Interventional, controlled clinical trial with two arms, 110 Veterans with TBI and PTSD
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>March 2014</start_date>
  <completion_date type="Anticipated">March 2016</completion_date>
  <primary_completion_date type="Anticipated">March 2016</primary_completion_date>
  <phase>Phase 0</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Caregiver), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Level of Community Integration</measure>
    <time_frame>baseline assessment will be done within 3 month post-injury and the follow-up assessment up to 6 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Greater score on social reintegration scale</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">110</enrollment>
  <condition>Traumatic Brain Injury</condition>
  <condition>Post-Traumatic Stress Disorder</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The COMPASS (Community Participation through Self-Efficacy Skills Development) program aims at developing and testing a novel patient-centered intervention framework that can be utilized as a platform for VA community re-integration comparative effectiveness research.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Fifty-five participants in the supported discharge, or control, group will not receive the intervention.
Control</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Experimental - COMPASS</intervention_name>
    <description>Controlled randomized clinical trail</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Control - COMPASS</intervention_name>
    <description>Increased hours of patient-provider interactions Group. Fifty-five participants in the intervention group will receive eight goal self-management sessions over a period of approximately ten weeks.</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  DC VA Medical Center

        Exclusion Criteria:

          -  Unable to provide informed consent and no proxy available.

          -  Severe impairment of language or day- to-day memory that would preclude participation
             in a verbally-based therapy.

          -  Life expectancy of less than 36 months.

          -  Severe multiple trauma (as judged by the attending physicians and/or investigators
             that is too severe to participate in this study) such as:

               -  severe burns

               -  serious organ damage

               -  amputations

               -  multiple fractures

          -  History of substance abuse severe enough to cause neurologic damage, pre-morbid
             history of neurologic disease (e.g., stroke).

          -  Prior history of known bipolar disorder or schizophrenia or severe psychiatric
             illness as determined by medical history.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alexander Libin, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Washington DC VA Medical Center, Washington, DC</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Alexander Libin, PhD</last_name>
    <phone>(301) 951-8603</phone>
    <email>Alexander.Libin2@va.gov</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Marc R Blackman, MD</last_name>
    <phone>(202) 745-8478</phone>
    <email>Marc.Blackman@va.gov</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Washington DC VA Medical Center, Washington, DC</name>
      <address>
        <city>Washington</city>
        <state>District of Columbia</state>
        <zip>20422</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Delphyne Bruner</last_name>
      <phone>202-745-8328</phone>
      <email>Delphyne.Bruner@va.gov</email>
    </contact>
    <investigator>
      <last_name>Alexander Libin, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2014</verification_date>
  <lastchanged_date>February 21, 2014</lastchanged_date>
  <firstreceived_date>March 19, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Stress Disorders, Post-Traumatic</mesh_term>
    <mesh_term>Stress Disorders, Traumatic</mesh_term>
    <mesh_term>Brain Injuries</mesh_term>
    <mesh_term>Wounds and Injuries</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
